You are reading 1 of 2 free-access articles allowed for 30 days
This year’s conference will bring together regulators, professional
bodies, health services, medication safety innovators and local and international representative bodies. The conference topics will address key elements of reducing avoidable harm from medications by examining: Inspection against quality standards; Medication-related litigation;
Innovative approaches to systematic capture of medication
errors and near-misses; Current risk reduction strategies for high
alert medications National and international responses to the
WHO Medication Without Harm Global Patient Safety Challenge.
Anticipated outcomes for attendees and the health system are a
shared understanding of respective roles in reducing harm from
medication errors and a shared vision for a systematic, collaborative
open approach to improving patient safety by preventing avoidable harm.
The IMSN has applied to NMBI and RCPI for continuing education credits.
A draft agenda is available from the website www.imsn.ie/events.